Clinical experiences with urokinase
Fischer, M.
Folia Haematologica 95(2): 145-157
1971
ISSN/ISBN: 0323-4347 PMID: 4106003 Document Number: 42799
Document emailed within 1 workday
Related Documents
Dayi, H.; Zhimin, X. 1997: Evaluation of the patency rate of infarct-related artery after intravenous urokinase in acute myocardial infarction by 90 minutes angiography. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(3): 184-186Kirchheimer, J.C.; Nong, Y.H.; Remold, H.G. 1988: IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes Journal of Immunology 141(12): 4229-4234
Ueno, T.; Kobayashi, N.; Maekawa, T. 1979: Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase Thrombosis and Haemostasis 42(3): 885-894
Collen, D.; De Cock, F.; Lijnen, H.R. 1984: Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys Thrombosis and Haemostasis 52(1): 24-26
Geratz, J.D.; Shaver, S.R.; Tidwell, R.R. 1981: Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation Thrombosis Research 24(1-2): 73-83
Andrassy, K.; Ritz, E. 1978: Biochemistry and clinical significance of urokinase Deutsche Medizinische Wochenschrift 103(24): 1011: 1015-1020
de Maat, M.P.; Dooijewaard, G.; Meijer, P.; Binder, B.R.; Keber, D.; Risberg, B.; Kluft, C.; Jespersen, J. 2001: Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 453-458
Bizzi, B.; Leone, G.; Tutinelli, F.; Landolfi, R. 1978: Thrombolytic therapy with urokinase. Clinical trials La Clinica Terapeutica 86(5): 419-432
Shiba, T.; Igarashi, M.; Takeuchi, S.; Awazu, S.; Asada, T. 1978: Experimental and clinical studies on thrombolytic therapy with urokinase Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(4): 771-781
Schmitt, M.; Goretzki, L.; Jänicke, F.; Calvete, J.; Eulitz, M.; Kobayashi, H.; Chucholowski, N.; Graeff, H. 1991: Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer Biomedica Biochimica Acta 50(4-6): 731-741
Hu, D.; Xu, Z. 1997: Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocardial infarction. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(11): 839-842
Torppa, M.Auri.; Kuikka, L.; Nevalainen, M.; Pitkälä, K.Hannele. 2016: Family physician experiences with and needs for clinical supervision: Associations between work experiences, professional issues and social support at work Patient Education and Counseling 99(7): 1198-1202
Ochocińska, A.; Jarmużek, W.; Janas, R. 2018: The clinical pattern of nephrotic syndrome in children has no effect on the concentration of soluble urokinase receptor (suPAR) in serum and urine Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 44(262): 183-187
Ibba, G.V.; Terrosu, P.; Franceschino, V.; Contini, G.; Frau, G. 1983: Intracoronary thrombolytic treatment with urokinase in myocardial infarct: clinical angiographic findings and effects on left ventricular function Giornale Italiano di Cardiologia 13(8): 75-84
Lubbe, N.; Seitz, W.; Bornscheuer, A.; Verner, L. 1989: Erste klinische Erfahrungen mit dem S & W Kaloximet®, einem Gerät zur O2-Verbrauchsmessung in Anaesthesie und Intensivmedizin - Premières expériences cliniques du Kaloximet S et W* un appareil pour mesurer la consommation d'O2 en anesthésie et soins intensifs - First clinical experiences with the S & W Kaloximet, a device for oxygen consumption measurement der Anaesthesist (Berlin. Print) 38(3): 147-151
Simonsen, E.; Mellergård, M. 1986: The MCMI--Millon Clinical Multiaxial Inventory. Clinical experiences with a new questionnaire for assessing psychiatric patients Ugeskrift for Laeger 148(44): 2872-2875
Cremonini, V.; Ferri, P.; Artioli, G.; Sarli, L.; Piccioni, E.; Rubbi, I. 2015: Nursing students' experiences of and satisfaction with the clinical learning environment: the role of educational models in the simulation laboratory and in clinical practice Acta Bio-Medica: Atenei Parmensis 86(Suppl 3): 194-204
Kraska, T.; Zochowski, R.J.; Korewicki, J.; Opolski, G.; Pieniak, M. 1978: Preliminary clinical experiences with continuous intravenous nitroglycerin infusion in the treatment of acute myocardial infarct. Preliminary clinical communication Kardiologia Polska 21(4): 301-308
Salomon, G.; Elberling, C. 1971: E.R.A. clinical system and clinical experiences Nordisk Medicin 86(35): 1032
Kusakari, J.; Sato, Y.; Saijo, S.; Tomioka, S.; Kawamoto, K. 1978: Clinical experiences with pepleomycin (NK 631) Japanese Journal of Antibiotics 31(11): 659-663